Qlaris Bio, Inc.
Clinical trials sponsored by Qlaris Bio, Inc., explained in plain language.
-
New eye drops aim to boost blood flow for diabetic retinopathy and glaucoma patients
Disease control Recruiting nowThis early study tests whether QLS-111 eye drops can improve blood flow in the back of the eye for people with diabetic retinopathy or certain types of glaucoma. About 14 participants will use the drops and have their eye blood flow measured over several weeks. The goal is to see…
Phase: PHASE2 • Sponsor: Qlaris Bio, Inc. • Aim: Disease control
Last updated May 13, 2026 16:00 UTC
-
New eye drop combo aims to lower glaucoma pressure
Disease control Recruiting nowThis study is testing a new preservative-free eye drop combination (QLS-111-FDC) to see how well it lowers eye pressure in people with open-angle glaucoma or ocular hypertension. About 60 participants will receive the study drops and be monitored for safety and comfort. The goal …
Phase: PHASE2, PHASE3 • Sponsor: Qlaris Bio, Inc. • Aim: Disease control
Last updated Apr 30, 2026 15:50 UTC